R Fleishman1, C Zhou2, C Gleason3, C Larison4, M T Myaing4, R Mangione-Smith2. 1. Division of Neonatology, St Christopher's Hospital for Children, Philadelphia, PA, USA. 2. 1] Department of Pediatrics, University of Washington, Seattle, WA, USA [2] Seattle Children's Research Institute, Seattle, WA, USA. 3. Department of Pediatrics, University of Washington, Seattle, WA, USA. 4. Seattle Children's Research Institute, Seattle, WA, USA.
Abstract
OBJECTIVE: To test whether implementing a nursing-driven comfort protocol standardizes morphine use in one neonatal intensive care unit (NICU) and to examine how non-standard morphine (N-SM) relates to days of ventilation, days of total parenteral nutrition (TPN) and length of stay (LOS). STUDY DESIGN: This was a retrospective/prospective observational study using pharmacy records, medical records, and an outcomes database. Comfort protocol implementation began February 2011 and was applied to preterm, ventilated neonates <1500 grams. Pre- and post-implementation proportions of N-SM days were compared using the binomial test. A percent 'P'-chart spanning 30 quarters was constructed with statistical-process control analysis. Multivariable linear regression adjusting for acuity assessed the relationship between N-SM use and days of ventilation, TPN and LOS. RESULT: Hundred and thirty-four patients met inclusion criteria, 116 prior to and 18 after implementation. The proportion of patients given N-SM for one or more days decreased from 59 to 35% after protocol implementation (P = 0.017). A 9-month period of decreased N-SM days was observed after protocol implementation. Controlling for acuity, each additional day of N-SM use was associated with 0.47 more days of ventilation (95% confidence interval (CI): 0.26-0.69, P < 0.001) and 0.52 more days of TPN (95% CI: 0.35-0.68, P < 0.001). Exposure to N-SM was associated with 17 additional days of hospitalization (P = 0.009, 95% CI: 4.5-30). CONCLUSION: Implementing a nursing-driven comfort protocol significantly reduced N-SM use. N-SM in the NICU is negatively associated with key clinical outcomes. Testing similar protocols in other settings is warranted.
OBJECTIVE: To test whether implementing a nursing-driven comfort protocol standardizes morphine use in one neonatal intensive care unit (NICU) and to examine how non-standard morphine (N-SM) relates to days of ventilation, days of total parenteral nutrition (TPN) and length of stay (LOS). STUDY DESIGN: This was a retrospective/prospective observational study using pharmacy records, medical records, and an outcomes database. Comfort protocol implementation began February 2011 and was applied to preterm, ventilated neonates <1500 grams. Pre- and post-implementation proportions of N-SM days were compared using the binomial test. A percent 'P'-chart spanning 30 quarters was constructed with statistical-process control analysis. Multivariable linear regression adjusting for acuity assessed the relationship between N-SM use and days of ventilation, TPN and LOS. RESULT: Hundred and thirty-four patients met inclusion criteria, 116 prior to and 18 after implementation. The proportion of patients given N-SM for one or more days decreased from 59 to 35% after protocol implementation (P = 0.017). A 9-month period of decreased N-SM days was observed after protocol implementation. Controlling for acuity, each additional day of N-SM use was associated with 0.47 more days of ventilation (95% confidence interval (CI): 0.26-0.69, P < 0.001) and 0.52 more days of TPN (95% CI: 0.35-0.68, P < 0.001). Exposure to N-SM was associated with 17 additional days of hospitalization (P = 0.009, 95% CI: 4.5-30). CONCLUSION: Implementing a nursing-driven comfort protocol significantly reduced N-SM use. N-SM in the NICU is negatively associated with key clinical outcomes. Testing similar protocols in other settings is warranted.
Authors: Joke de Graaf; Richard A van Lingen; Abraham J Valkenburg; Nynke Weisglas-Kuperus; Liesbeth Groot Jebbink; Barbara Wijnberg-Williams; Kanwaljeet J S Anand; Dick Tibboel; Monique van Dijk Journal: Pain Date: 2012-12-20 Impact factor: 6.961
Authors: K J S Anand; R Whit Hall; Nirmala Desai; Barbara Shephard; Lena L Bergqvist; Thomas E Young; Elaine M Boyle; Ricardo Carbajal; Vinod K Bhutani; Mary Beth Moore; Shari S Kronsberg; Bruce A Barton Journal: Lancet Date: 2004-05-22 Impact factor: 79.321
Authors: Sinno H P Simons; Monique van Dijk; Richard A van Lingen; Daniella Roofthooft; Hugo J Duivenvoorden; Niesje Jongeneel; Carin Bunkers; Enna Smink; K J S Anand; John N van den Anker; Dick Tibboel Journal: JAMA Date: 2003-11-12 Impact factor: 56.272
Authors: G Menon; E M Boyle; L L Bergqvist; N McIntosh; B A Barton; K J S Anand Journal: Arch Dis Child Fetal Neonatal Ed Date: 2007-12-18 Impact factor: 5.747
Authors: Ruth E Grunau; Michael F Whitfield; Julianne Petrie-Thomas; Anne R Synnes; Ivan L Cepeda; Adi Keidar; Marilyn Rogers; Margot Mackay; Philippa Hubber-Richard; Debra Johannesen Journal: Pain Date: 2009-05 Impact factor: 6.961
Authors: D Rana; B Bellflower; J Sahni; A J Kaplan; N T Owens; E L Arrindell; A J Talati; R Dhanireddy Journal: J Perinatol Date: 2017-06-15 Impact factor: 2.521
Authors: David F Grabski; Rick D Vavolizza; Sarah Lepore; Daniel Levin; Sara K Rasmussen; Jonathan R Swanson; Eugene D McGahren; Jeffrey W Gander Journal: Pediatrics Date: 2020-11-12 Impact factor: 7.124